FDA Inspection
Delaware Valley OB/GYN & Infertility Group P.C.Delaware Valley OB/GYN & Infertility Group P.C. – FDA Inspection, Jul 30, 2013
Record Details
This FDA Inspection record concerns Delaware Valley OB/GYN & Infertility Group P.C., with an inspection on July 30, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- July 30, 2013
- Product Type
- Biologics
View Company Profile
ID · 191c8c53-d077-42e2-9d3e-92a3a0e16e3b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 842608
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
3- 21 CFR 1271.47(b)Review and approval of procedures
- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Delaware Valley OB/GYN & Infertility Group P.C.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| May 21, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 23, 2011 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Delaware Valley OB/GYN & Infertility Group P.C.
- FDA Inspection 936825 - 2015-05-21
- FDA Inspection 715488 - 2011-03-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.